JFS Wealth Advisors’s bluebird bio BLUE Stock Holding History

JFS Wealth Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5	Closed	-$25	–	1885
2025 Q1	$25	Hold	5	–	–	﹤0.01%	1916
2024 Q4	$42	Buy	+5	New	+$44	﹤0.01%	1910
2022 Q1	–	Sell	-1	Closed	–	–	1826
2021 Q4	$0	Buy	+1	New	+$236	﹤0.01%	1721

Other funds holding BLUE

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JFS Wealth Advisors's BLUE Position: Q2 2025 in Review

JFS Wealth Advisors sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 5 shares — an estimated $25 sold.

JFS Wealth Advisors first reported a position in BLUE in Q4 2021 and held it in 3 quarters. The position peaked at $42 in Q4 2024. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

JFS Wealth Advisors reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
JFS Wealth Advisors sold 5 bluebird bio shares in Q2 2025, an estimated $25.
JFS Wealth Advisors first reported a position in bluebird bio in Q4 2021 and held it in 3 quarters.
JFS Wealth Advisors's bluebird bio position peaked at $42 in Q4 2024.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on JFS Wealth Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.